About This Role
The Rare Neurology Development Unit (RNDU) at Biogen is accountable for developing innovative therapies for spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS), and rare movement disorders (RMD), such as Friedreich ataxia (FA) and Huntington’s disease.